PT86831A - Process for preparing sustained release matrix formulations - Google Patents

Process for preparing sustained release matrix formulations

Info

Publication number
PT86831A
PT86831A PT86831A PT8683188A PT86831A PT 86831 A PT86831 A PT 86831A PT 86831 A PT86831 A PT 86831A PT 8683188 A PT8683188 A PT 8683188A PT 86831 A PT86831 A PT 86831A
Authority
PT
Portugal
Prior art keywords
sustained release
release matrix
matrix formulations
preparing sustained
preparing
Prior art date
Application number
PT86831A
Other languages
English (en)
Other versions
PT86831B (pt
Inventor
Peter Lloyd Oren
Werner Max Karl Seidler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT86831A publication Critical patent/PT86831A/pt
Publication of PT86831B publication Critical patent/PT86831B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PT86831A 1987-02-27 1988-02-25 Processo para a preparacao de formulacoes de matriz de libertacao retardada PT86831B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1991587A 1987-02-27 1987-02-27

Publications (2)

Publication Number Publication Date
PT86831A true PT86831A (pt) 1988-03-01
PT86831B PT86831B (pt) 1992-05-29

Family

ID=21795732

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86831A PT86831B (pt) 1987-02-27 1988-02-25 Processo para a preparacao de formulacoes de matriz de libertacao retardada

Country Status (26)

Country Link
EP (1) EP0280571B1 (pt)
JP (1) JPH082793B2 (pt)
KR (1) KR960005140B1 (pt)
CN (1) CN1023765C (pt)
AR (1) AR243376A1 (pt)
AT (1) ATE92309T1 (pt)
AU (1) AU604849B2 (pt)
CA (1) CA1316110C (pt)
CY (1) CY1741A (pt)
DE (2) DE3882739T2 (pt)
DK (1) DK175620B1 (pt)
EG (1) EG18523A (pt)
ES (1) ES2044825T3 (pt)
GR (1) GR930300027T1 (pt)
HK (1) HK125793A (pt)
HU (1) HU202747B (pt)
IE (1) IE61419B1 (pt)
IL (1) IL85538A (pt)
LV (1) LV10184B (pt)
MX (1) MX10558A (pt)
NZ (1) NZ223619A (pt)
PH (1) PH24358A (pt)
PT (1) PT86831B (pt)
RU (1) RU1831337C (pt)
UA (1) UA18251A (pt)
ZA (1) ZA881301B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
DE69131688T2 (de) * 1990-05-04 2000-05-25 Perio Products Ltd., Hahotzvim System zur arzneistoffabgabe im colon
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
CA2174538A1 (en) * 1993-10-22 1995-04-27 Michio Nagasawa Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
JP3707798B2 (ja) * 1996-05-13 2005-10-19 ノバルティス・コンシューマー・ヘルス・ソシエテ・アノニム 口内薬剤輸送系
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
CA2322432C (en) * 1998-03-03 2005-12-20 Daewoong Pharmaceutical Co., Ltd. Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
ATE400251T1 (de) * 1999-02-09 2008-07-15 Pfizer Prod Inc Zusammensetzungen basischer arzneistoffe mit verbesserter bioverfügbarkeit
KR100647901B1 (ko) * 1999-07-09 2006-11-17 보령제약 주식회사 세파클러-함유 서방성 약제조성물 및 그의 제조방법
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
DE60034368T2 (de) 1999-12-28 2008-01-03 Kimberly-Clark Worldwide, Inc., Neenah Verwendungs-abhängiges indikatorsystem für absorbierende artikel
US6734157B2 (en) 1999-12-28 2004-05-11 Kimberly-Clark Worldwide, Inc. Controlled release anti-microbial hard surface wiper
BR0016354B1 (pt) 1999-12-28 2012-09-18 método de formação de um pano de limpeza antimicrobiano e pano de limpeza.
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
ATE266407T1 (de) * 2000-10-30 2004-05-15 Lupin Ltd Schnell zerfallende cefuroxim axetil enthaltende arzneizusammensetzung mit verzögerter wirkstoffabgabe
EP1589951B1 (en) * 2003-01-03 2017-08-09 Supernus Pharmaceuticals, Inc. Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
ES2360423T3 (es) 2006-04-26 2011-06-03 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
CA2669324C (en) * 2006-11-13 2012-06-19 Kyorin Pharmaceutical Co., Ltd. Method for preparing sustained release tablet
CN102438617A (zh) 2009-03-27 2012-05-02 杏林制药株式会社 含有碱性添加剂的基质型缓释制剂
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
JP6456377B2 (ja) * 2014-06-10 2019-01-23 ライオン株式会社 清酒酵母を含有する錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151913B (pt) * 1980-01-11 1983-09-03 Boots Co Ltd
JPS6024765B2 (ja) * 1981-11-27 1985-06-14 辰巳化学株式会社 セフアレキシンの持続性製剤の製造方法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法

Also Published As

Publication number Publication date
RU1831337C (ru) 1993-07-30
NZ223619A (en) 1990-10-26
MX10558A (es) 1993-11-01
HK125793A (en) 1993-11-19
EP0280571B1 (en) 1993-08-04
AU1219388A (en) 1988-09-01
ZA881301B (en) 1989-10-25
HU202747B (en) 1991-04-29
EP0280571A2 (en) 1988-08-31
PH24358A (en) 1990-06-13
JPH082793B2 (ja) 1996-01-17
EP0280571A3 (en) 1989-01-04
CA1316110C (en) 1993-04-13
DK98088D0 (da) 1988-02-25
ES2044825T1 (es) 1994-01-16
ATE92309T1 (de) 1993-08-15
CN88101062A (zh) 1988-09-07
EG18523A (en) 1993-04-30
IL85538A (en) 1991-09-16
JPS63227519A (ja) 1988-09-21
ES2044825T3 (es) 1994-11-16
IE61419B1 (en) 1994-11-02
KR960005140B1 (ko) 1996-04-22
IE880545L (en) 1988-08-27
PT86831B (pt) 1992-05-29
DE3882739D1 (de) 1993-09-16
LV10184A (lv) 1994-10-20
CY1741A (en) 1995-02-17
LV10184B (en) 1995-04-20
HUT46531A (en) 1988-11-28
GR930300027T1 (pt) 1993-05-24
DK175620B1 (da) 2004-12-27
DK98088A (da) 1988-08-28
DE280571T1 (de) 1993-08-12
UA18251A (uk) 1997-12-25
IL85538A0 (en) 1988-08-31
KR880009639A (ko) 1988-10-04
AR243376A1 (es) 1993-08-31
CN1023765C (zh) 1994-02-16
DE3882739T2 (de) 1994-02-17
AU604849B2 (en) 1991-01-03

Similar Documents

Publication Publication Date Title
PT86831A (pt) Process for preparing sustained release matrix formulations
FI885884L (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
PH25376A (en) Oral sustained release acetaminophen formulation, process
FI905683L (fi) Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi
PT86866A (pt) Process for preparing piperazinyl-heterocyclic compounds
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
EP0306236A3 (en) Controlled release formulations
FI881180L (fi) Menetelmä terapeuttisesti käytettävien tetrahydronaftaleenijohdannaisten valmistamiseksi
NZ225101A (en) Sustained release composition
FI870588A7 (fi) Menetelmä hitaasti vapauttavan kiinteän annostusmuodon valmistamiseksi
PT87030A (pt) Process for preparing a sustained release microbiological control composition containing a halogenated amide
FI884575L (fi) Menetelmä tetrasykliinikoostumusten valmistamiseksi, joilla on kontrolloitu vapautuminen
FI896062A7 (fi) Granulaatit lääkeainetta ohjatusti vapauttavia koostumuksia varten
PT86660A (pt) Process for preparing adenosine 5:-carboxamide derivatives
FI885497L (fi) Irrokeainekoostumus
PT87218A (pt) Process for preparing substituted pyrroles
FI881303A7 (fi) Menetelmä ibuprofeenin valmistamiseksi
BR8802172A (pt) Conjunto porta-matriz
PT84213A (en) Process for preparing a long acting sustained release pharmaceutical composition
FI880467A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI883672A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI885838A7 (fi) Menetelmä tioformamidijohdannaisten valmistamiseksi
PT87564A (pt) Process for preparing substituted vinylcephalosporins useful as medicaments
PT88493A (pt) Process for preparing milbemycin derivatives useful as antiparasitic agents
PT87672A (pt) Process for preparing a pharmaceutical composition

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911113

NF3A Restitutio in integrum

Effective date: 19930923

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080225